Creve Coeur, MO, United States of America

Toshihiro Kita

This inventor holds 1 USPTO granted patent. Top assignee: G.d. Searle & Company. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihiro Kita. Retrieved from https://idiyas.com/inventor/toshihiro-kita-e0v4j0re

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshihiro Kita: Innovator in Peptide Research

Introduction

Toshihiro Kita is a notable inventor based in Creve Coeur, MO (US). He has made significant contributions to the field of peptide research, particularly in the area of intestinal fluid absorption. His work has implications for various medical applications.

Latest Patents

Toshihiro Kita holds a patent for a novel peptide known as Human uroguanylin. This peptide is disclosed as being useful for the control of intestinal fluid absorption. The amino acid sequence of this peptide is critical for its functionality.

Career Highlights

Kita is associated with G.D. Searle & Company, where he has been able to apply his expertise in peptide research. His innovative approach has led to advancements in understanding how peptides can influence bodily functions.

Collaborations

Throughout his career, Toshihiro Kita has collaborated with notable colleagues, including Kam F. Fok and Christine E. Smith. These collaborations have enriched his research and contributed to the development of new ideas in the field.

Conclusion

Toshihiro Kita's work in peptide research exemplifies the impact of innovation in medical science. His contributions continue to pave the way for advancements in understanding intestinal fluid absorption.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…